Biotechnology Company Reports: research reports

... The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Osiris ...  |  more...

... specializes in various fields such as, biomarker development, gene expression analysis, formalin-fixed paraffin-embedded tumor tissue analysis, gene mutation analysis, cell-free circulating dna, nanofluids, and immunohistochemistry and FISH. Pangaea Biotech also operates a standard ISO 15189:2007 ...  |  more...

... serum derived from 200,000 volunteers. These serums find application in identifying major age related diseases which thereby assist in investigations related to screening diagnostics. The company works together with the University College London and in ...  |  more...

... kidney and pancreas. Currently, the company focuses on the development and production of biomesh from porcine organ tissue for abdominal wall and hernia repair and breast reconstruction. Miromatrix Medical is headquartered in Eden Prairie, Minnesota, ...  |  more...

... as molecular investigation and contract research activities on real-time PCR and PCR platforms. Its pipeline projects include rapid detection and differentiation of torch infections; and evaluation of laccase production. Its tests adhere to standards of ...  |  more...

... a bioactive layered scaffold which has applications in the repair and regeneration of osteochondral defects. Its HydroxyColl ia a bone graft substitute which helps helps the body to create its own natural healing process from ...  |  more...

... cutting edge products. Ceres Nanosciences' product portfolio comprises Nanotrap ESP, Lyme Dx and Nanotrap RVFV. It also has collaborations with Shimadzu Scientific Instruments, SAIC-Frederick and United States Anti-Doping Agency. The company is headquartered at Manassas, ...  |  more...

... series of novel biomarkers in various phases of development. It comprises of individual markers and multi-marker panels for developing prognostic tests for cardiovascular indications, which include stroke, myocardial infarction, and peripheral artery disease. Currently, the ...  |  more...

... tissue in a targeted, non-invasive manner via patterned vibrations. The technology finds application in various areas such as, epilepsy, pain, depression and mood disorder, diagnostic brain mapping, and cognitive abilities and communication. The company's U+ ...  |  more...

... to license the licensors monoclonal antibody technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest monoclonal antibody deals announced in the healthcare ...  |  more...

... products and services, swot analysis, business description, and company history. Summary This report is a crucial resource for industry executives and anyone looking to access key information about Celgene Corporation The report utilizes a wide ...  |  more...

... its business segments such as, RG Laboratory Tests, RG Diagnostic Products, RG MicroRNA Technology and RG Therapeutic Products. RGL conducts several diagnostic test development programs in the fields of oncology and women’s health. The company ...  |  more...